Clinical Evaluation of the Nova Max Pro StatSensor Device

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT07392710

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07392710
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07392710. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-02-02 (actual); primary completion 2024-12-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Evaluation of the Nova Max Pro StatSensor Device
Condition
Kidney Transplant
Condition
Kidney Disease, Chronic
Intervention (Device)
Nova Max Pro StatSensor device
Lead sponsor
Royal Free Hospital NHS Foundation Trust (class: other)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct07392710
Content hash
43eb71e7e16b9cee0875ffc032e942f25854555836254b57a0e12b0abe7b44d6